Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportCardiovascular

Relationship between the standardized uptake value (SUV) and left ventricular ejection fraction (LVEF) in patients with cardiac sarcoidosis (CS)

Hiroshi Ohira, Brian McArdle, Eugene Leung, David Birnie, Robert deKemp, Jean DaSilva, Linda Garrard, Ann Guo, Rob Beanlands and Pablo Nery
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1682;
Hiroshi Ohira
1University of Ottawa Heart Institute, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian McArdle
1University of Ottawa Heart Institute, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eugene Leung
2The Ottawa Hospital, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Birnie
1University of Ottawa Heart Institute, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert deKemp
1University of Ottawa Heart Institute, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean DaSilva
1University of Ottawa Heart Institute, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Garrard
1University of Ottawa Heart Institute, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Guo
1University of Ottawa Heart Institute, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rob Beanlands
1University of Ottawa Heart Institute, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Nery
1University of Ottawa Heart Institute, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1682

Objectives The purpose of our study was to determine the effect of Anti-inflammatory therapy (AIT) on FDG SUV and LVEF and determine the relationship of the change in LVEF and the change in SUV in a cohort of patients with CS.

Methods 14 patients with CS were recruited. Fasting whole body and cardiac FDG-PET was performed. LV SUV (mean and maximum) was determined. LVEF was evaluated by gated N-13 ammonia or Rb-82 PET at baseline and follow-up. The changes of the LVEF classified into 3 categories; improved: absolute LVEF increased >/= 10%; no change: LVEF change < 10%; deteriorated: LVEF decreased >/=10%.

Results All 14 patients showed focal FDG uptake in the LV at baseline. 12 patients had AIT (treatment group) and 2 patients were observed without AIT. In the treatment group, the max SUVs in the LV after AIT were significantly decreased compared to those at the baseline (8.40+/-2.70 vs 3.40+/-1.65; p=0.0002) (similar degree of change for overall mean SUVs) but EF did not change (44.3+/-17.0 vs 41.9+/-13.8; p=0.72). 8 out of 12 (67%) showed more than 50% reduction in SUVs at follow-up period: 2 had increased LVEF and 1 had reduced EF and 5 had no change. In the remaining 4 patients in the treatment group with less reduction in SUVs, 3 patients no change in LVEF, 1 patient showed deterioration of LVEF. In the 2 patients without AIT, 1 patient demonstrated more than 50% reduction in SUVs with improvement of LVEF, 1 patient showed no reduction in SUVs with no change in LVEF. There was no significant relationship between the change in max SUVs and change in EF (r2=0.04;p=0.48).

Conclusions In this small cohort, while AIT was associated with a significant reduction of FDG SUV with 8/12 patients having more than 50% reduction, there was not a significant effect on change in LVEF. Also 1/2 patients without AIT had a more than 50% reduction in SUV. Larger prospective studies are warranted.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Relationship between the standardized uptake value (SUV) and left ventricular ejection fraction (LVEF) in patients with cardiac sarcoidosis (CS)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Relationship between the standardized uptake value (SUV) and left ventricular ejection fraction (LVEF) in patients with cardiac sarcoidosis (CS)
Hiroshi Ohira, Brian McArdle, Eugene Leung, David Birnie, Robert deKemp, Jean DaSilva, Linda Garrard, Ann Guo, Rob Beanlands, Pablo Nery
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1682;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Relationship between the standardized uptake value (SUV) and left ventricular ejection fraction (LVEF) in patients with cardiac sarcoidosis (CS)
Hiroshi Ohira, Brian McArdle, Eugene Leung, David Birnie, Robert deKemp, Jean DaSilva, Linda Garrard, Ann Guo, Rob Beanlands, Pablo Nery
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1682;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Cardiovascular

  • Cardiac β-Adrenergic Receptor Downregulation, Evaluated by Cardiac PET, in Chronotropic Incompetence
  • Diagnostic Performance of PET Versus SPECT Myocardial Perfusion Imaging in Patients with Smaller Left Ventricles: A Substudy of the 18F-Flurpiridaz Phase III Clinical Trial
  • Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with 18F-LW223, a Novel TSPO Radiotracer with Binding Independent of the rs6971 Human Polymorphism
Show more Cardiovascular

MTA II: Cardiovascular (Clinical) Posters

  • Dependency of Rb-82 normal distribution on PET camera and processing
  • Prognostic value of simultaneous myocardial perfusion imaging (MPI) and coronary calcium score (CCS) assessment in patients with intermediate likelihood of CAD: A 5-year follow-up study
  • Reproducibility of left ventricular ejection fractions using PET blood flow and metabolism tracers: Rb-82, N-13-ammonia and F-18-FDG
Show more MTA II: Cardiovascular (Clinical) Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire